2014
DOI: 10.1080/03079457.2014.974504
|View full text |Cite
|
Sign up to set email alerts
|

Factors influencing the outcome of infectious bronchitis vaccination and challenge experiments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
41
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(42 citation statements)
references
References 98 publications
1
41
0
Order By: Relevance
“…IB still causes serious problems in the Iraqi poultry industry due to the inability of the vaccines to provide cross-protection between different genotypes [1]. The genotyping of IBV is necessary not only for understanding virus evolution but also for effective modification of the vaccination programs [10]. In this study, the infection rate of IBV was 32 %, which indicated widespread distribution of IBV in the southern and middle parts of Iraq.…”
Section: Discussionmentioning
confidence: 66%
“…IB still causes serious problems in the Iraqi poultry industry due to the inability of the vaccines to provide cross-protection between different genotypes [1]. The genotyping of IBV is necessary not only for understanding virus evolution but also for effective modification of the vaccination programs [10]. In this study, the infection rate of IBV was 32 %, which indicated widespread distribution of IBV in the southern and middle parts of Iraq.…”
Section: Discussionmentioning
confidence: 66%
“…Clinical respiratory symptoms in both groups were mild, but comparable (not shown). As the severity of IBV clinical symptoms also relies on environmental factors, including but not limited to cold and heat stress, food additives and the presence of secondary bacterial or viral infections [22], the severity of clinical symptoms in an experimental setting is often less than in the field [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…Currently, the most effective control measure is vaccine application, which proved to effectively reduce clinical signs emergence, infectious pressure and viral population size, at least when properly performed 4,5 . However, this approach cannot be considered a panacea, and some drawbacks cannot be denied.…”
mentioning
confidence: 99%